New monoclonal antibodies that recognize an unglycosylated, conserved, extracellular region of CD44 in vitro and in vivo, and can block tumorigenesis

作者
Daniel F. Lusche,Deborah J. Wessels,Ryan J. Reis,Cristopher C. Forrest,A. THUMANN,David R. Soll
出处
期刊:PLOS ONE [Public Library of Science]
卷期号:16 (4): e0250175-e0250175 被引量:7
标识
DOI:10.1371/journal.pone.0250175
摘要

CD44 is a transmembrane glycoprotein that binds to hyaluronic acid, plays roles in a number of cellular processes and is expressed in a variety of cell types. It is up-regulated in stem cells and cancer. Anti-CD44 monoclonal antibodies affect cell motility and aggregation, and repress tumorigenesis and metastasis. Here we describe four new anti-CD44 monoclonal antibodies originating from B cells of a mouse injected with a plasmid expressing CD44 isoform 12. The four monoclonal antibodies bind to the terminal, extracellular, conserved domain of CD44 isoforms. Based on differences in western blot patterns of cancer cell lysates, the four anti-CD44 mAbs separated into three distinct categories that include P4G9, P3D2, and P3A7, and P3G4. Spot assay analysis with peptides generated in Escherichia coli support the conclusion that the monoclonal antibodies recognize unglycosylated sequences in the N-terminal conserved region between amino acid 21-220, and analyses with a peptide generated in human embryonic kidney 293 cells, demonstrate that these monoclonal antibodies bind to these peptides only after deglycosylation. Western blots with lysates from three cancer cell lines demonstrate that several CD44 isoforms are unglycosylated in the anti-CD44 target regions. The potential utility of the monoclonal antibodies in blocking tumorigenesis was tested by co-injection of cells of the breast cancer-derived tumorigenic cell line MDA-MB-231 with the anti-CD44 monoclonal antibody P3D2 into the mammary fat pads of mice. All five control mice injected with MDA-MB-231 cells plus anti-IgG formed palpable tumors, while only one of the six test mice injected with MDA-MB-231 cells plus P3D2 formed a tiny tumor, while the remaining five were tumor-free, indicating that the four anti-CD44 mAbs may be useful therapeutically.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
1秒前
可爱的函函的应助被江南脆饼采纳,获得10
1秒前
2秒前
海绵宝宝完成签到,获得积分20
2秒前
2秒前
科研通AI6.3的应助被神勇的筝采纳,获得30
3秒前
小杨肖恩完成签到,获得积分10
3秒前
Royal完成签到,获得积分10
3秒前
Rainvin发布了新的文献求助10
3秒前
www完成签到,获得积分10
4秒前
Mxy发布了新的文献求助10
4秒前
王钰绮完成签到,获得积分10
5秒前
风兮发布了新的文献求助10
5秒前
xxwang完成签到,获得积分20
5秒前
5秒前
JamesPei的应助被大意的凝芙采纳,获得20
5秒前
踏实白梦完成签到,获得积分10
6秒前
英俊冷风发布了新的文献求助10
7秒前
mm发布了新的文献求助10
7秒前
是小叮当完成签到 ,获得积分10
7秒前
Hello的应助被金三顺采纳,获得10
7秒前
领导范儿的应助被xxwang采纳,获得10
8秒前
科研通AI6.4的应助被Royal采纳,获得10
8秒前
深情安青的应助被风中的宛白采纳,获得10
8秒前
9秒前
青青草原青草蛋糕完成签到 ,获得积分10
9秒前
zsn完成签到,获得积分10
10秒前
纯真的滑板完成签到,获得积分10
10秒前
噜噜噜发布了新的文献求助10
10秒前
fengling完成签到,获得积分10
10秒前
Tessa完成签到,获得积分10
12秒前
12秒前
神经蛙发布了新的文献求助60
14秒前
能不能给我来篇SSCI完成签到,获得积分10
14秒前
14秒前
14秒前
研友_8KXdRL发布了新的文献求助10
14秒前
小蘑菇的应助被聪慧远山采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181408
求助须知:如何正确求助?哪些是违规求助? 9571330
关于积分的说明 21817615
捐赠科研通 7777856
什么是DOI,文献DOI怎么找? 3433479
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479527